Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they…
Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk…
Substituting trastuzumab emtansine (T-DM1, Kadcyla) for adjuvant trastuzumab (Herceptin) in patients who had residual disease…
Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days…
Black women with the most common form of early breast cancer had worse outcomes than…
Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of…
Circulating tumour-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline…
Patients with early-stage breast cancer who had cancer detected in a sentinel lymph node biopsy…
Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival…
Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had…